Epping MT - Search Results

1

ZNF423 is critically required for retinoic acid-induced differentiation and is a marker of neuroblastoma outcome.

Huang S, Laoukili J, Epping MT, Koster J, Hölzel M, Westerman BA, Nijkamp W, Hata A, Asgharzadeh S, Seeger RC, Versteeg R, Beijersbergen RL, Bernards R. Huang S, et al. Among authors: epping mt. Cancer Cell. 2009 Apr 7;15(4):328-40. doi: 10.1016/j.ccr.2009.02.023. Cancer Cell. 2009. PMID: 19345331 Free PMC article.

2

The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling.

Epping MT, Wang L, Edel MJ, Carlée L, Hernandez M, Bernards R. Epping MT, et al. Cell. 2005 Sep 23;122(6):835-47. doi: 10.1016/j.cell.2005.07.003. Cell. 2005. PMID: 16179254 Free article.

3

Molecular basis of the anti-cancer effects of histone deacetylase inhibitors.

Epping MT, Bernards R. Epping MT, et al. Int J Biochem Cell Biol. 2009 Jan;41(1):16-20. doi: 10.1016/j.biocel.2008.07.020. Epub 2008 Aug 12. Int J Biochem Cell Biol. 2009. PMID: 18765293 Review.

4

UNC45A confers resistance to histone deacetylase inhibitors and retinoic acid.

Epping MT, Meijer LA, Bos JL, Bernards R. Epping MT, et al. Mol Cancer Res. 2009 Nov;7(11):1861-70. doi: 10.1158/1541-7786.MCR-09-0187. Epub 2009 Oct 20. Mol Cancer Res. 2009. PMID: 19843631

5

A causal role for the human tumor antigen preferentially expressed antigen of melanoma in cancer.

Epping MT, Bernards R. Epping MT, et al. Cancer Res. 2006 Nov 15;66(22):10639-42. doi: 10.1158/0008-5472.CAN-06-2522. Cancer Res. 2006. PMID: 17108098 Free article. Review.

6

A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors.

Epping MT, Wang L, Plumb JA, Lieb M, Gronemeyer H, Brown R, Bernards R. Epping MT, et al. Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17777-82. doi: 10.1073/pnas.0702518104. Epub 2007 Oct 29. Proc Natl Acad Sci U S A. 2007. PMID: 17968018 Free PMC article.

7

PRAME expression and clinical outcome of breast cancer.

Epping MT, Hart AA, Glas AM, Krijgsman O, Bernards R. Epping MT, et al. Br J Cancer. 2008 Aug 5;99(3):398-403. doi: 10.1038/sj.bjc.6604494. Epub 2008 Jul 22. Br J Cancer. 2008. PMID: 18648365 Free PMC article.

8

TSPYL5 suppresses p53 levels and function by physical interaction with USP7.

Epping MT, Meijer LA, Krijgsman O, Bos JL, Pandolfi PP, Bernards R. Epping MT, et al. Nat Cell Biol. 2011 Jan;13(1):102-8. doi: 10.1038/ncb2142. Epub 2010 Dec 19. Nat Cell Biol. 2011. PMID: 21170034

9

Genome-wide loss-of-function screen reveals an important role for the proteasome in HDAC inhibitor-induced apoptosis.

Fotheringham S, Epping MT, Stimson L, Khan O, Wood V, Pezzella F, Bernards R, La Thangue NB. Fotheringham S, et al. Among authors: epping mt. Cancer Cell. 2009 Jan 6;15(1):57-66. doi: 10.1016/j.ccr.2008.12.001. Cancer Cell. 2009. PMID: 19111881 Free article.

10

Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma: in vitro and phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition.

Dummer R, Beyer M, Hymes K, Epping MT, Bernards R, Steinhoff M, Sterry W, Kerl H, Heath K, Ahern JD, Hardwick JS, Garcia-Vargas J, Baumann K, Rizvi S, Frankel SR, Whittaker SJ, Assaf C. Dummer R, et al. Among authors: epping mt. Leuk Lymphoma. 2012 Aug;53(8):1501-8. doi: 10.3109/10428194.2012.656625. Epub 2012 Feb 13. Leuk Lymphoma. 2012. PMID: 22239668 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page